A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-18-0584
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Sensitivity of BRCA1/2 Mutation Testing in 466 Breast/Ovarian Cancer Families

Journal of Medical Genetics
Genetics
2003English

A Patient Decision Aid for Risk-Reducing Surgery in Premenopausal BRCA1/2 Mutation Carriers: Development Process and Pilot Testing

Health Expectations
EnvironmentalPublic HealthOccupational Health
2017English

Cost Effectiveness of the Cancer Prevention Program for Carriers of the BRCA1/2 Mutation

Revista de Saude Publica
MedicineEnvironmentalPublic HealthOccupational Health
2018English

What Are the Unmet Support Needs of Women With a Known BRCA1/2 Mutation?

Hereditary Cancer in Clinical Practice
OncologyGenetics
2012English

Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis

Breast Diseases
OncologySurgery
2013English

Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening

Diagnostics
Clinical Biochemistry
2019English

Review Of: A DGGE System for Comprehensive Mutation Screening of BRCA1 and BRCA2: Application in a Dutch Cancer Clinic Setting

Breast Cancer Online
2007English

Genotype–phenotype Correlation in BRCA1/2 Mutation-Associated Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy